Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
T. Rowe Price Equity Income ETF (TEQI) belongs to the US Multi-Factor segment. Columbia Research Enhanced Value ETF (REVS) is part of the US Large Cap Value segment. TEQI's top 3 sector exposures are Financials, Industrials and Health Care. In contrast, REVS's top sector exposures are Financials, Health Care and Industrials. TEQI is more expensive with a Total Expense Ratio (TER) of 0.54%, versus 0.19% for REVS. TEQI is up 0.95% year-to-date (YTD) with -$1M in YTD flows. REVS performs better with 1.84% YTD performance, and +$74M in YTD flows. Run a side-by-side ETF comparison of TEQI and REVS below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | TEQI REVS | -4.69%-3.72% | +0.73%+0.55% | +0.95%+1.84% | +13.02%+19.40% | +48.79%+60.84% | +53.92%+71.76% |
| Flows | TEQI REVS | +$2M+$13M | +$10M+$79M | -$1M+$74M | +$45M+$138M | +$202M+$173M | +$277M+$193M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | TEQI REVS | +10.42%+10.96% | +15.71%+15.96% | +13.20%+13.35% | +15.19%+15.12% |
| Max drawdown | TEQI REVS | -4.75%-4.35% | -12.68%-12.32% | -14.73%-16.16% | -17.81%-17.78% |
| Max drawdown duration | TEQI REVS | 17d30d | 77d46d | 213d211d | 624d448d |
TEQI | REVS | |
Last sale 3/13/2026 at 1:30 PM | $44.97 | $28.38 |
| Previous close 03/12/2026 | $45.00 | $28.45 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
TEQI | REVS | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
TEQI | REVS | |
|---|---|---|
| Last price | $44.97 | $28.38 |
| 1D performance | -0.07% | -0.25% |
| AuM | $370.01 M | $213.52 M |
| E/R | 0.54% | 0.19% |
TEQI | REVS | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | T. Rowe Price | Columbia Threadneedle Investments |
| Benchmark | - | Beta Advantage Research Enhanced U.S. Value Index |
| N° of holdings | 109 | 281 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 23, 2020 | September 25, 2019 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
